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Abstract  
Discrete events and processes influence development of individual future humans. 
While we do not wish to redefine personhood, we relate a newly discovered epigenetic 
event to sources of individuality of future humans. Genetic and epigenetic events and 
developmental milieu processes diversify developmental trajectories of future individual 
humans prior to societal entry via parturition. First, fertilization and epigenetic resetting 
of each individual’s organismic clock to time zero (t=0) at day 15 of embryogenesis, are 
two discrete discreet biological events that impact a future individual human’s attributes. 
Second, those two discrete discreet biological events are immersed in the continuous 
developmental process spanning pre-fertilization and gestation, further driving 
individualization of diverse attributes of each future human before the discrete blatant 
biological event of parturition (birth) and societal entry. Exposures of the gravida to 
multiple diverse exogenous exposures means that morphogenesis and physiogenesis 
of every embryo/fetus has individualized attributes for its future human lifespan. 
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Background 
Across human history, by introducing an individual human into society, the discrete, 
blatant biological event of parturition marked the attribution of and beginning of 
personhood for that individual human. In recent decades, the concept of personhood 
has been elaborated and debated in multiple contexts including legal, theological, 
scientific and philosophical. Notably, discourses relating to the time at which 
personhood can be attributed to a developing potential or future human have oftentimes 
reached divergent conclusions (Kerckhove and Waller 1998; White 2013). It is our 
current contention that both new and well-established scientific insights can provide a 
framework by which such considerations regarding future human individuality can be 
better made. In the scientific realm, advances in reproductive technologies across 
recent decades necessitated carefully considered ethical and scientific assessments 
and implementation of guidelines for medical and scientific practices  (Ethics Advisory 
Board 1979; Warnock 1984). As scientific knowledge has accumulated about human 
birth, gestation, implantation, fertilization, gametes, and genetics, the beginning of 
human personhood has been defined by various endpoints related to each of these 
biological processes (Warnock 1984). Associated with each such biological endpoint, 
ethical, legal, theological and social interpretations have been superimposed. Herein we 
propose that recent epigenetic discoveries disclose a new basis for both a) unique non-
genetic individual pre-fertilization attributes to gametes (oocytes and spermatozoa) by 
heritability of parental epigenetics and more importantly, b) demonstration of a resetting 
of organismic epigenetic time by a molecular embryonic event at the time of 
gastrulation/formation of the primitive streak (Kerepesi et al. 2021). It is important to 
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note that we do not wish to redefine personhood or argue for a specific definition of the 
term. We are simply presenting our scientific and ethical framework of prepartum 
human development to highlight how this newly identified biological event should be 
integrated into future discussions regarding personhood and prenatal acquisition of 
many attributes of future individual humans. 
Pre-Societal Determinative Transformational Events for Future Individual Humans 
Many genetic, epigenetic, and developmental milieu effects from pre-conception 
through birth determine that individual's unique combination of attributes upon societal 
entry. For our purposes in this paper, we define three terms as follows: 
1. Potential human: The stages of human development spanning initial interactions 
of one female and one male gamete such as the spermatozoa binding to the 
zona pelucida up to formation of the primitive streak.  
2. Future human: The stages of human development spanning the embryo at the 
primitive streak stage that has undergone resetting of the epigenetic clock 
through parturition and birth.  
3. Physiogenesis: The partner concept to morphogenesis; meaning the acquisition 
of molecular, cellular, tissue, organ, system and organismic level functions to 
allow future individual life.  
We present our framework that a future human becomes an individual by the overlaying 
of a complex individualization process onto the three known discrete determinative 
events, namely fertilization, the novel epigenetic time reset and birth. 
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A) Although we are arguing that a novel biological parameter that should be considered 
in assessing personhood for future individual humans is the resetting of the epigenetic 
clock at approximately Day 15 of embryonic life as recently demonstrated by Kerepesi 
et al (2021), 
B) we also argue that it is insufficient to reflect on determination of personhood by any 
parameter without also considering the process of pre-societal developmental 
individualization of future humans. A spectrum of factors influences acquisition of 
individuality prior to entry into society (birth).  
Individualization of attributes occurs both before and after the epigenetic reset of time 
zero and the acquisition of such attributes may be genetic or non-genetic. There are 
three discrete events and multiple continual/continuous processes that determine the 
individual attributes of a future individual human. Across the course of development, 
becoming an individual is a process, and individualization is, in fact, a summation of all 
of the developmental determinants that cause or modify the acquisition of biologically 
definable metabolic, morphologic, behavioral, and reproductive attributes. 
The Two Discrete Discreet Events of Fertilization and Epigenetic Time Reset 
1. Fertilization and Parental Genetics. It is widely understood that the genetic attributes 
of each individual are robustly dependent upon parental genomes and that individual 
diversity within a population is profoundly dependent upon random assortment of alleles 
and meiotic recombination that had occurred in parental gametogenesis. In the process 
of recombination, crossing over appears to be essential for correct segregation of 
homologous chromosomes. In the first meiotic division, there are two major meiotic 
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recombination pathways that are initiated by DNA double-stranded breaks. The two 
major recombination pathways are the crossover pathway via formation of chiasmata at 
metaphase I, and the non-crossover pathway which does not involve formation of 
chiasmata but can produce “gene conversion” which is effectively a double crossover of 
a short DNA segment. (Handel and Schimenti 2010) 
The key biological consequence of these processes in gametogenesis is diversification 
of the genomes of progeny. Each array of inherited genes provides combinations that 
may mimic or diverge from the phenotypic traits of the parents, because most human 
traits are a product of a non-Mendelian complex interaction of multiple genes. (de 
Magalhães and Wang 2019) 
2. Epigenetics and the Epigenetic Organismic Clock Reset to Time Zero (t=0) on 
Embryonic day 15.  The broad context of epigenetics in human embryonic development 
is that there is a general “wiping the slate clean” but also a rather modest degree of 
retention of some parental epigenetic marks (Figure 1).  This predominant but 
incomplete erasure of epigenetic marks has attracted great research interest as well as 
debate about how important or unimportant epigenetic inheritance may be for any 
individual (Boskovic and Rando 2018; Heard and Martienssen 2014; Osumi & Tatehana 
2021; Soubry et al. 2021; Thompson and Einstein 2010; Tuscher and Day 2019). 
As an outgrowth of epigenetics research in the embryo, Kerepesi et al. (2021) have 
focused on the opportunity to assess temporality of epigenetic events. Their recent 
publication makes the case that they have characterized the time and event that is THE 
beginning of aging for each individual mammal. From Kerepesi et al. (2021): 
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“…we developed a new multi-tissue epigenetic clock using machine learning and 
applied it, together with other existing aging clocks, to assess prenatal development 
in mammals from the perspective of aging. This approach uncovered a rejuvenation 
period during early embryogenesis and the timing of the beginning of aging in 
mammals. [In the mouse] ...the epigenetic age dynamics showed a clear U-shaped 
pattern in every case… Organismal aging begins after this rejuvenation event…The 
observed epigenetic age minimum at E6.5/E7.5 corresponds to gastrulation, the 
period where the three germ layers are formed…  
Our study suggests that the germ line ages but is rejuvenated in the offspring at 
some point during early embryogenesis. This rejuvenation occurs during early post-
implantation stages corresponding to gastrulation when the offspring reaches its 
minimal biological age. We propose that this minimum, the ground zero, marks the 
beginning of aging of an organism… The data indicate that ground zero lies 
between E4.5 and E10.5 in mice, most probably at E6.5/E7.5. This period 
corresponds to the germ-layer specification (gastrulation) accompanied by the exit 
from pluripotency…  
The beginning of aging is subject to debate. It is often discussed that aging begins 
after completion of development, at the onset of reproduction, and at the time when 
strength of natural selection begins to decrease. However, our recent analysis of 
deleterious age-related changes revealed that aging begins early in life, even before 
birth (61).  
Our current work now pinpoints the beginning of aging to ground zero… Overall, 
this work identifies a natural rejuvenation event during early life and suggests that 
 
Page 8 of 39 
 
organismal aging begins during embryogenesis, approximately at the time of 
gastrulation." 
Diverse Developmental Milieu Factors Influence Pre-Fertilization, Embryonic and Fetal 
Attributes of Future Individual Humans 
The range of potential cell types during human in utero development that might be 
affected by exogenous factors are not yet fully elucidated, but there is a global effort 
underway to do precisely that; namely, to create a comprehensive reference map of 
cells during development (Haniffa et al 2021). Even though the precise identity of 
cellular targets during development are not fully known, stochastic environmental and 
intrauterine milieu factors are known to impact the developmental trajectory of future 
humans (Thompson and Einstein 2010; Skogen and Overland 2012). Considerations of 
such effects in individual humans fall within a number of scientific and medical 
disciplines, but no matter the exposure-outcome scenario or any assessed need for 
therapeutic interventions (Hughes et al 2016), the core concepts such as growth and 
differentiation are basic biology. The conceptual challenge in development with or 
without exogenous perturbations is to formalize how emergent properties arise via 
dynamic interactions at both higher and lower levels of biological organization. Such 
theoretical and analytical network modeling research is occurring (Cavigelli et al 2021), 
with, for example, more than 100 studies currently underway under the auspices of the 
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Structure and function are inextricably intertwined in all of biology, and development is 
the sequential process by which the integration of morphology and physiology in a 
future organism advance and may permit that individual organism to attain life. 
Disruptions of development occur and there is a long history of scientific study of such 
variations from the normative patterns. Specifically, the scientific discipline of teratology 
was historically rooted in morphogenesis and disorders thereof, and we assert that the 
later broader term of developmental toxicology had helped add dynamic integrated 
elements that we herein call “physiogenesis” as its sine qua nom, as it focuses on how 
exposures to various physical, chemical, biological and social factors may adversely 
affect the health and functional well-being of an individual human. 
While teratology/developmental toxicology research primarily seeks to understand 
adverse effects of the many exposures that inevitably occur during development of an 
individual human, it is widely acknowledged that many exposures will either have 
healthful effects or have no plausible impact on the future well-being of that individual 
human. Thus, we offer an inverse view that taken in toto, whether adverse, salutary or 
neutral, the effects of diverse developmental exposures alter the developmental 
trajectories of each future individual human and consequently provide countless 
patterns of individualization of all future humans (Figure 2). 
After implantation, the fetal environment and the fetal developmental trajectory is 
obviously dependent upon maternal metabolism (nutritional adequacy, excesses or 
inadequacies), intentional exposures (dietary choices, personal habits, substance use 
or abuse, etc.), environmental/unintentional exposures (physical, chemical or  infectious 
agents and familial and socioeconomic stressors), as well as maternal pre-pregnancy 
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comorbid diseases and obstetrical disorders such as gestational diabetes, preterm 
labor, and early or late onset preeclampsia. All of these factors (see Hughes & Waters 
2016, multi-authored chapters 3-10) may influence fetal development and thereby 
nudge the fetus along a different developmental path than is followed by others. Once 
again, each of these types of exposure during development modify that future human 
and diversifies the spectrum of persons who later enter society at parturition. 
There are a number of classes of exposures that are well-known to affect human 
development prior to birth. Some of these prenatal exposures are quite specific such as 
drugs prescribed to pregnant women to treat an underlying disease (Bastow et al 2017; 
Dutta 2015); while others are generalized such as inhaled fine to ultrafine particulates 
that appear to adversely affect infants’ respiratory and immune systems, brain 
development, and cardiometabolic health (Johnson et al 2021). Additionally, there are 
many exposures that are not proven with certainty to affect human prenatal 
development but are widely thought to be probable or possible human 
teratogens/developmental toxicants. The following are brief profiles of the key classes of 
such developmentally influential agents. 
Mutagens. All humans are exposed to mutagens (American Cancer Society 2021) 
including oxidative stress, ionizing radiation, naturally occurring compounds such as 
mycotoxins as well as environmental contaminants and pharmaceutical agents. 
Exposures to mutagens and consequent stochastic mutagenic effects (Verheyen, van 
Deun, and van Miert 2017) during the stages of parental gametes, zygote, embryo and 
fetal intervals are a source of de novo mutations that are acquired differences in an 
individual's genome. These individualization effects are dependent upon the several 
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characteristics of the exposure such as the compound or compounds, the dose, the 
duration, the timing during developmentally sensitive windows, and the individual's or 
maternal genetics that may modify resistance to or susceptibility to the effects of 
mutagens in various tissues and organ systems. 
Prior to fertilization, the individuality of a potential human derives from the genetic 
diversity among the oocytes and spermatozoa that were produced by the potential 
parents. Obviously, the genetics of the potential mother and father are profoundly 
important in determining spectrum of individual possibilities for that potential human. 
Another source of individuality can derive from the age of the parents, particularly the 
father. The reasoning is that the prolonged decades of sperm production offer more 
opportunities for de novo mutations to occur and be present in spermatozoa that may 
participate in fertilization of an oocyte (As reviewed by Osumi & Tatehana 2021). From 
Coorens et al (2021): 
“From fertilization onwards, cells of the human body continuously experience 
genomic damage, either from intrinsic causes or exogenous exposure to mutagens. 
Although almost all DNA damage is repaired and the genome is replicated with 
extremely high fidelity, cells steadily acquire somatic mutations throughout life. 
Some mutations that are present in a cell are shared with other cells. Because 
identical mutations rarely happen by chance, shared mutations often indicate a 
shared developmental history. Once gained, mutations are rarely lost. Thus, past 
developmental relationships from embryonic, fetal, childhood and adult phases of 
life can be identified from mutations in adult cells…This research exemplifies 
somatic mutations as lineage tracing markers of human development. By 
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constructing phylogenies from many normal tissue samples, it is possible to deduce 
the life history of a cell from its inception as a zygote, through embryogenesis and 
early development to its final destination as a differentiated adult cell…This 
research demonstrates the variability of human embryogenesis in the shaping of 
different lineages and tissues through developmental bottlenecks. Understanding 
patterns of normal human development can contextualize disorders of development, 
especially when caused by post-zygotic genomic aberrations, such as early drivers 
of childhood cancers or mosaic overgrowth syndromes. Further studies using 
somatic mutations as natural lineage markers may help to address fundamental 
questions of human ontogeny.” 
Non-Mutagens. Some chemical exposures are intentional such as use of medicinal 
drugs or substances that are recreational or addictive that may be legal or illicit. 
Maternal exposures to these classes of compounds, particularly during pregnancy, are 
known in many instances to produce adverse effects on the embryo or fetus. Less clear-
cut but potentially quite important are exposures to these classes of bioactive chemicals 
of either parent prior to or during gametogenesis, fertilization, implantation and 
embryonic stages of development. 
Since it is widely reported that only about one half of all pregnancies are planned, a vast 
majority of women take at least one prescription drug during pregnancy, and 
approximately two thirds take a medicinal drug of some sort during the first trimester, 
there are numerous pharmaceutical drugs that have been reported to cause birth 
defects when exposures occurred in utero (Bastow et al 2017; Capra et al 2013; Dutta 
2015). Even for common over-the-counter medications such as those containing 
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acetaminophen (paracetamol), there is justification for considering that fetal 
developmental effects on neurological, reproductive and urogenital systems may occur 
(Bauer et al 2021). It is worth noting that the terminology used to describe associations 
of developmental effects in the setting of maternal use of medicinal drugs may seem 
somewhat tentative and focused primarily on more prominent effects typically called 
birth defects. Some uncertainty about associating prescription or over-the-counter 
medication use with developmental effects is valid because the mother typically has an 
active disease or undiagnosed signs and symptoms, any of which may present certain 
risks per se to the fetus; then the usage of a drug is superimposed in that setting. 
Nonetheless, regulatory authorities require manufacturers to report such adverse events 
through safety reporting systems and such data demonstrate to some extent the 
potentialities for effects in the offspring.  
The other prominent class of voluntary chemical exposures that could impact 
development in utero or during lactation are recreational or addictive substances. As 
noted currently by the U.S. National Institute on Drug Abuse (2021), these include 
marijuana (cannabis), stimulants (cocaine and methamphetamine), MDMA (3,4-Methyl
enedioxymethamphetamine, Ecstasy, Molly), opioids (heroin, diverted prescription 
opiates), alcohol (ethanol) and nicotine (tobacco products and e-cigarettes). The 
scientific literature demonstrating the impact of these classes of exposures and the 
broad range of developmental effects is truly massive (NIDA 2021) and unequivocal.    
Less certain but of potential significance is the suggestive evidence from a number of 
research reports showing that exposures that precede the fetal interval may pose an 
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explicit morphogenic developmental risk or have a physiogenic effect that only 
manifests in the offspring long after birth. We shall cite one of each for illustration.  
First, in a recent meta-analysis, Zhang et al (2019) studied the relationship between 
parental alcohol exposure and risk of congenital heart disease (CHD) in their offspring. 
In the pooling of data from more than 50 studies with >40,000 CHD cases and >290,000 
controls, there was the expected finding of an increased risk with maternal alcohol 
exposures (odds ratio (OR) = 1.16; 95% confidence interval (CI): 1.05–1.27) but also 
with paternal (OR = 1.44; 95% CI: 1.19–1.74) alcohol exposures. To the best of our 
knowledge, the molecular or cellular mechanisms underlying this reported risk are 
unknown. 
Second, Northstone et al (2014) used the Avon Longitudinal Study of Parents and 
Children’s questionnaire data on smoking and smoking onset from >9800 fathers and 
the data regarding growth of their children from 7–17 years. In brief, after adjusting for 
potential confounders, the investigators found that for the men who reported regular 
smoking at <11 years of age, the adjusted mean differences in BMI, waist 
circumference and total fat mass in their sons were significantly greater from age 13 
years onwards.  From the concept that “Smoking by boys in mid childhood may 
contribute to obesity in adolescent boys of the next generation.” Northstone et al 2014), 
Hammer et al (2021) recently reported data from their work in an animal (mouse) model  
offering a degree of mechanistic explanation for non-genomic transmission of such 
observations about paternal physiogenic effects on their offspring as follows: “miRNAs 
in the plasma microenvironment of spermatozoa may represent a mechanism for 
transmittable epigenetic changes to offspring and development of metabolic or 
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respiratory diseases, further highlighting paternal smoking as potential risk factor for 
offspring’s health.” These data strengthen the idea that tobacco smoking by human 
male teenagers increases the risk of overweight and obesity in their male offspring. 
Another group of embryonic/fetal exposures is parental diseases. Numerous chronic or 
recurrent diseases occur in women who become pregnant, sustain the pregnancy, and 
undergo labor and delivery. The range of such concurrent illnesses that could potentially 
impact growth and development of each future human was demonstrated by Jolving et 
al (2016) in their nationwide (Denmark) registry-based cohort study that included all 
women who gave birth (> 1.3 million) between 1989 and 2013. These investigators 
specified 23 maternal chronic diseases within the decade preceding childbirth. While 
noting that the overall prevalence of maternal chronic disease increased from 3.71% in 
1989 to 15.76% in 2013, the ten most prevalent diseases during pregnancy were 
chronic lung disease/asthma (1.73%), thyroid disorders (1.50%), anxiety and personality 
disorders (1.33%), mood disorders (0.74%), epilepsy (0.69%), inflammatory bowel 
diseases (0.67%), polycystic ovarian syndrome (0.52%), diabetes mellitus (0.48%), 
hypertension (0.43%) and rheumatoid arthritis (0.38%). 
While much remains unknown about the potential impacts of many such comorbid 
conditions on a fetus during gestation, several maternal diseases that frequently occur 
during pregnancy are known to impact fetal development, ofttimes posing risks to 
normal in utero growth and development. To the extent that potential fetal 
developmental effects of medications used to treat such diseases can be assessed and 
set aside, there are still clear attributable risks to the fetus if the gravida has one or 
more comorbid diseases. Such demonstrated risks include fetal growth (small for 
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gestational age/low birth weights or high birth weights) but also metabolic and 
neurocognitive effects in the neonate and the child. For example, associations of 
maternal comorbidities during pregnancy and perinatal and childhood outcomes include 
(Capra et al 2013; Lahti-Pulkkinen et al 2020) the following: 
- Maternal depression with low birth weight infant and later central adiposity in the 
child; 
- Maternal diabetes (type 1, type 2 or gestational), hyperglycemia or obesity with 
high birth weight infant and later metabolic syndrome and obesity in the child; 
- Maternal overweight/obesity with higher likelihood of autism spectrum disorders 
or neurodevelopmental delays; 
- Maternal asthma (with exacerbations) with increased risk of preterm delivery and  
low birth weight infant (particularly in males); 
- Maternal sleep deprivation and sleep-related breathing disorders with low birth 
weight infant (small for gestational age) and a higher risk of mortality; 
- Maternal anemia with low birth weight infant (intrauterine growth retardation) and 
increased risk of preterm delivery; and 
- Maternal hypertensive disorders of pregnancy (gestational and chronic 
- hypertension, preeclampsia) with higher likelihood of childhood mental disorders.    
While it may seem intuitive that maternal diseases during pregnancy could logically 
impact outcomes of her infant, some data show that paternal health also influences the 
health of his infant. It is reasonable to suppose that the father’s health could be a 
genetic precursor of sorts for his infant or that cohabitation of the two parents might lead 
to predisposing environmental effects on their offspring. However, at least some 
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interesting correlations that may be causations were suggested by Kasman et al (2020) 
in their inquiry about whether prepartum and neonatal outcomes are associated with 
pre-existing paternal health factors. In this retrospective cohort study in the United 
States of children born between 2009-2016, paternal health status as reflected in 
diagnoses of various chronic diseases was compared to the primary outcome of 
preterm birth (meaning live birth before 37 weeks), as well as several secondary 
outcomes including low birth weight, neonatal intensive care unit (NICU) stay, 
gestational diabetes, preeclampsia, eclampsia, and length of maternal stay. By use of a 
research database covering reimbursed health care claims data on inpatient and 
outpatient encounters through employment-sponsored health insurance, the 
investigators assessed 785,809 singleton live births, with 6.6% born preterm. 
Kasman et al (2020) reported “The presence of paternal comorbidities was associated 
with higher odds of preterm birth, low birth weight (LBW), and NICU stay. After adjusting 
for maternal factors, fathers with most or all components of the metabolic syndrome had 
19% higher odds of having a child born preterm (95% CI 1.11–1.28), 23% higher odds 
of LBW (95% CI 1.01–1.51), and 28% higher odds of NICU stay (95% CI 1.08–1.52). 
Maternal morbidity (e.g., gestational diabetes or preeclampsia) was also positively 
associated with preconception paternal health.” These findings suggest but do not 
causally establish that preconception paternal comorbidities may modestly influence 
obstetrical and neonatal outcomes. 
In addition to those parental disease and drugs exposures, the future human is subject 
to numerous other chemical, social, stochastic obstetrical and microbiological 
exposures that are known or suspected to impact human embryonic/fetal development. 
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It is not possible to fully review all of these embryonic/fetal exposures compounds in this 
document, but we will describe a few notable classes. 
There are hundreds of naturally-occurring and man-made compounds that have been 
demonstrated to be present in either amniotic fluid (Foster et al 2000; Foster et al 2002; 
Hughes et al 2001) or umbilical cord blood (Wang et al 2021), raising the reasonable 
prospect that at least some of them may influence development.  
One prominent group of compounds has been named “endocrine-disrupting chemicals” 
(EDCs) which means “an exogenous chemical, or mixture of chemicals, that can 
interfere with any aspect of hormone action” (Endocrine Society 2018). There is now 
broad agreement but not consensus that “Individuals and populations are exposed to 
EDCs, and common non-communicable diseases have been associated with 
environmentally-relevant doses of EDCs in human epidemiological studies…It is now 
well established that developmental exposure to EDCs can alter the epigenome of 
offspring, affecting gene expression and organogenesis, thereby altering an organism´s 
sensitivity to disease later in life.(Endocrine Society 2018).” More recent research into 
the potential neurodevelopmental effects of EDCs (Lopez-Rodriguez et al 2021), 
suggest that some effects may include alterations in brain development that advance or 
delay puberty or alter neuroendocrine control of reproduction thus impairing fertility. 
Various data suggest that neurodevelopmental effects of EDCs may occur via action on 
steroidal and non-steroidal receptors but also via alterations in enzymatic, metabolic 
and epigenetic and other cellular pathways during development (Lopez-Rodriguez et al 
2021). It may be possible to link such mechanistic complexity of EDC actions to various 
individual neuropsychiatric outcomes by use of network analysis tools. In an upcoming 
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paper, Raja et al (2022) report that such an analysis seems to show that genes, 
receptors and signaling pathways interact as a consequence of exposures to EDCs and 
in turn are associated with disorders such as major depression, alcoholism, psychotic 
disorders, autism spectrum disorder, attention-deficit/hyperactivity disorder (ADHD), 
cerebral palsy, and sex-specific aggressive and emotional behavior. 
In addition to those parental disease and drugs and environmental chemical exposures, 
maternal environmental stressors (natural disasters; famine, social stressors) also 
influence development of her offspring. 
Tragic large-scale disasters have served as natural (or man-made) experiments 
wherein many pregnant women were exposed to various forms of deprivation or other 
stressors, and subsequent assessments of their offspring have shown a number of 
important health effects.  
One such well-recognized event was the Dutch famine of 1944-1945. Even now, 
decades later, additional reports are being published that demonstrate the life-long 
persistence of the in utero developmental effect(s) that occurred. Lumey et al (2021) 
analyzed the heights and weights of 371,100 men in the Netherlands when they were 
examined for military service at age 19 years. The men born between 1943 and 1947 
either did or did not experience prenatal exposure to the Dutch famine. These 
investigators found that there was an overall 1.3-fold increase in the risk of being 
overweight or obese at age 19 after prenatal famine exposure in early gestation, and 
the attendant  30% increase in overall mortality through age 63 relative to those with a 
normal BMI. 
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A second such large-scale disaster was the 1998 Quebec Ice Storm. Within the last few 
years, Paxman et al (2018) sought to gain some mechanistic insights into the 
physiological phenotypes seen in the population exposed in utero by use of proton 
nuclear magnetic resonance spectroscopy to analyze urinary metabolomes of male and 
female adolescents. Overall these investigators found that higher prenatal stress 
exposure led to alterations in metabolic pathways involved in energy metabolism and 
protein biosynthesis; findings that are consistent with dysregulation of energy and 
protein metabolism as would be expected in insulin resistance, diabetes, and obesity. 
Finally, a third such event was the Great Tangshan Earthquake (China) in 1976. In this 
instance, another recent study by Guo et al (2019) assessed data from >94,000 
Chinese individuals born between 1975 and 1979. The investigators studied the 
relationship between the occurrence of schizophrenia (diagnosed by psychiatrists) and 
earthquake severity by seismic intensity. In brief, in comparison to an unexposed 
cohort, the cohort exposed to the earthquake in utero had higher risk of schizophrenia 
(odds ratio, 3.38; 95% CI 1.43–8.00). Notably, when assessed by the trimester of 
pregnancy in which exposure occurred, earthquake exposure during the first trimester of 
pregnancy showed a further increased risk of adulthood schizophrenia (odds ratio, 7.45; 
95% CI 2.83–19.59). 
Though such disasters illustrate the impact that external factors may have on 
development, societal elements that broadly affect many more individual future humans 
are embedded in the concept of socio-economic status (SES) as a summary of the 
availability of material and social resources to any individual. Childhood SES is one of 
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the strongest predictors of lifelong well-being and appears to be associated with the 
duration and functional complexity of individual brain development (Tooley et al 2021). 
The cellular and molecular mechanisms that mediate such effects of SES or other social 
factors such as familial adversity are not fully understood, but epigenetics appear to 
play an important role (Tremblay et al 2016; Tremblay et al 2018). As noted by 
Tremblay et al (2016); 
“…there is now emerging evidence that early social-familial adversity leads to long 
lasting epigenetic alterations. These alterations may influence brain development, 
and, consequently, the ability to learn to regulate and control aggressive 
behaviour…In addition, the finding that many of these biological factors involved in 
chronic physical aggression develop very early (i.e., before birth), highlights the 
need to not only study the impact of the early postnatal environment on physical 
aggression, but also to take into account what is happening between conception 
and birth.” 
“Indeed, a number of studies have now identified perinatal risk factors for a wide 
variety of behavioral problems (e.g., hyperactivity, opposition, rule breaking) that are 
highly related to maternal characteristics and maternal behavior during pregnancy. 
The effects of the perinatal environment on gene expression is presently the most 
interesting hypothesis. However, the reader needs to realize that we are only 
starting to explore this avenue.” 
“The benefits of prevention starting as close as possible to conception seems 
obvious. If the earlier the risks the more widespread the negative effects, then the 
corollary is the earlier the preventive intervention the more widespread the benefits. 
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The later we intervene, the less chance we have to impact the basic weaknesses of 
the organism…Preventive interventions should help at risk pregnant women live a 
life style that will facilitate ‘normal’ gene expression.” 
Yet another variable that impacts development of some individual future humans  is 
what we have called stochastic obstetrical factors. The uterine microenvironment may 
be modified by any of the exposures described above, but there are occasional other 
presumably random events related to location and qualitative aspects of implantation 
and thus placentation per se. For example, if random implantation occurs over an 
underlying uterine leiomyoma (fibroid), then as the pregnancy progresses, that fetus 
may be subject to reduced placental perfusion or placental abruption events that could 
impact growth in utero, lead to premature delivery or pose a risk of hemorrhagic 
compromise or even stillbirth. Another variable that may be random or iatrogenic as part 
of infertility therapies is twinning, or higher multiple birth.    
Fetal and Maternal Microbiomes. 
New scientific discoveries demonstrate the impact of fetal and maternal microbiomes on 
prenatal development and perinatal outcomes.  
1) There is a fetal microbiome. New data show that in utero, as early as the second 
trimester, there are live microbes in healthy human fetal tissues (Mishra et al 2021); and  
2) The maternal vaginal microbiome influences the risk of preterm birth (Flaviani et al 
2021). 
The long-held “sterile womb” dogma has been fading as evidence for an in utero 
colonization hypothesis had become more substantiated (Perez-Muñoz, et al 2017). 
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New data show that fetal immunological development in utero at least in part depends 
upon prepartum exposure of each fetus to microbes; from (Mishra et al (2021):  
"The events occurring during fetal gestation are essential for the overall 
development and growth of the individual. Key factors transferred from the mother 
to the fetus during this process establish the cornerstones of early life immunity and 
life-long tolerance. Various studies have recently suggested that certain antigens as 
well as bacterial entities may cross the placental barrier and make their way to fetal 
organs… All these observations open a new avenue in developmental immune-
priming wherein maternal-derived microbial entities may condition the progeny 
toward future antigenic exposures in life. 
Our findings demonstrate that healthy human fetal tissues (in the 2nd trimester of 
gestation) contain effector T ems, a sparse biomass of bacteria, and an active 
memory T cell response toward fetal bacteria. We also demonstrate direct spatial 
localization of bacterial entities, localized within the lumen of developing fetal gut, 
during the 2nd trimester of gestation. These data are in line with recent studies that 
indicated antigenic priming of the fetal immune system begins during 
gestation…However, our study demonstrates for the first time that such microbial 
presence primes the fetal immune system, thereby putting early microbial memory 
in the context of fetal immune priming, a concept not explored before in fetal 
immunity…Taken together, these findings have wider implications in understanding 
the key factors involved in fetal immune system development and priming in utero, 
which may set the basis for life-long health and immunity of the organism…the 
existence of a spatially diverse microbial signal in fetal tissues, their ability to 
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culture-expand anaerobically, and the presence of microbial antigen-specific 
memory T cell activation, are difficult to reconcile with either systematic biases or 
random noise. Collectively, our data suggest a low but consistent presence of 
microbes in at least some of the healthy human fetuses in the 2nd trimester of 
gestation." 
While there is wide acceptance in obstetrics that vaginal organisms may contribute to 
ascending infections that produce chorioamnionitis and preterm labor and deliveries, 
new data show that even in the absence of intrauterine infections, the maternal vaginal 
microbiome influences the risk of preterm birth (Flaviani et al 2021). In their study of 
spontaneous preterm birth, Flaviani et al (2021) studied the interactions between the 
cervicovaginal metabolic environment and microbiota in tandem with the host innate 
immune response in a prospective United Kingdom (UK) longitudinal cohort of pregnant 
women. Analysis of cervicovaginal samples (10–15+6 weeks) identified potentially novel 
interactions between risk of spontaneous preterm birth (sPTB) and microbiota, 
metabolite, and maternal host defense molecules in an ethnically heterogenous 
pregnant population (n = 346 women; n = 60 sPTB < 37 weeks’ gestation, including n = 
27 sPTB < 34 weeks. 
These findings indicate that the maternal microbiome may poise a pregnancy to either 
be more likely to go to term, or to deliver prematurely and thereby impact an individual 
neonate and modify its post-natal developmental trajectory and ofttimes compromise 
one or more of its life-long functional outcomes. 
All of these sources of developmental diversification of individual future persons that 
spans the time and events from maternal and paternal gametogenesis across pre-
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fertilization, fertilization, implantation and embryonic and fetal development up to the 
time of parturition provide the background continual process that defines the 
characteristics of each future human prior to the discrete event of birth. 
The One Discrete Blatant Event of Parturition 
3. Birth and Societal Entry. 
The event that introduces a human into society is parturition, and this process presents 
its own set of challenges that may make a penultimate impact on the developmental 
outcome of the neonate. For the fetus, several maternal medical and obstetrical risk 
factors pose risks that may influence the infant’s lifelong health and functional status in 
diverse ways.  
In High Income Countries (HIC), some of the common maternal factors at the time of 
parturition that impact the neonate are hypertensive disorders of pregnancy (including 
preeclampsia), age, weight status, diabetes (pre-existing or gestational), substance use, 
depression, breech presentation and previous Cesarean birth(s) (Scrimshaw and 
Backes 2020). Additionally, among the most dangerous obstetrical complications during 
labor and delivery for the fetus are uterine rupture, shoulder dystocia, umbilical cord 
prolapse, chorioamnionitis and fetal macrosomia.  
In Low and Middle Income Countries (LMIC), the recent study by Baguiya et al (2021) 
show the devastating impact of maternal pre-existing conditions and suspected or 
confirmed infections on neonatal outcomes. This multinational team of investigators 
conducted a study in 2017 in 408 hospitals in 43 LMIC in all WHO regions. Women 
(n=1219) with suspected or confirmed infection during pregnancy at 28 weeks or more 
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of gestational age were followed, along with their infants, up to day 7 postpartum. 
Neonatal Near Miss (NNM) cases were defined by the criteria of birthweight <1750 
grams, gestational age at birth between 28 and 33 weeks, 5 min APGAR score <7, or  
use of any of several acute interventions (e.g., parenteral antibiotics, ventilation support, 
Intubation at birth or other medical or surgical interventions). These investigators 
reported neonatal outcomes to be   
1) 64% (n=780) babies alive without severe complications,  
2) 25.9% (n=316) were NNM cases and  
3) 10.1% (n=123) perinatal death (stillbirth and early neonatal death); 
and commented “Overall, one-third of births were adverse perinatal outcomes. Pre-
existing maternal medical conditions and severe infection-related maternal outcomes 
were the main risk factors of adverse perinatal outcomes." 
In multiple ways, whether births occur in HIC or LMIC, any of these peripartum risks 
may impact the fetus/neonate by causing cerebral palsy, Erb's palsy, hypoxic ischemic 
encephalopathy ("HIE") (perinatal asphyxia), cerebral hemorrhages, hematomas or 
periventricular leukomalacia ("PVL") as seen in premature infants. If PVL (which can 
lead to cerebral palsy or epilepsy) is seen as an overt consequence of premature birth, 
there is strong evidence of more subtle central nervous system developmental effects 
as well, since a recent study in a cohort of >4 million persons found that preterm and 
early term birth were associated with significantly increased risks of autism in boys and 
girls (Crump, Sundquist and Sundquist 2021).  
All of these diverse, mostly adverse, effects change the life-long trajectories of 
countless humans in multiple individualized ways.   
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How Do Medical and Scientific Research Guidances Relate to Our Scientific and 
Ethical Framework of Prepartum Human Development? 
In historical terms, as human in vitro fertilization procedures were developed and 
procedures were regularized in this area of medicine, reviews were conducted by multi-
disciplinary committees that provided insightful considerations from many diverse 
perspectives. Two leading examples were those published in the United States (Ethics 
Advisory Board 1979) and the United Kingdom (Warnock 1984). While the US panel’s 
report provided careful evaluative remarks on "The Status of the Early Human Embryo" 
(pages 27-33 and 48-51 in Ethics Advisory Board 1979), the UK panel’s report, widely 
called “The Warnock Report” also made careful evaluative remarks (pages 60-72 in 
Warnock for the Committee 1984) and proposed that human embryos should not be 
sustained in vitro for more than fourteen days for any purpose. In some jurisdictions 
(such as the UK), this proposal became law, and in virtually all portions of the globe, this 
interval became the explicit or de facto guidance for all clinics and laboratories that 
participated in human in vitro fertilization clinical practice and/or research. 
Over the subsequent decades, there have been countless discussions about the “14-
day rule;” however, only recently has a pertinent professional scientific society taken the 
step of formally changing their position. Specifically, in May 2021 the International 
Society for Stem Cell Research (International Society for Stem Cell Research 2021), 
issued their “Guidelines for Stem Cell Research and Clinical Translation” and included 
on page 12 their argument for changing and support for ending the 14 days post-
fertilization restriction. As expected, this new position has evoked great interest and 
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commentary among many medical and scientific professionals (Powell 2021; Sawai et 
al 2021). We hope that no matter the perspective of any person or the position of any 
organization engaged in this renewed discourse about the “14 day rule,” each will duly 
consider the framework we are presenting herein as they formulate their new or 
renewed points-of-view. 
Summary and Conclusions 
As modern scientific discoveries have revealed demonstrable facts about additional 
biological processes and events prior to birth, scientific and ethical considerations are 
pertinent to assess any other discrete or continuing components that contribute to 
individualization before the societal entry of an individual human by birth. While we do 
not attempt to redefine personhood or argue for a specific definition of the term, we  
highlight a newly discovered novel biological event, its role in the developmental 
trajectory of future individual humans and its relevance to discussions regarding the 
diverse sources of individuality of future humans. We present the genetic, epigenetic 
and developmental milieu events and processes that, when combined, produce the 
distinguishing features of a human prior to its entry into society via birth. Accordingly, 
we present the novel argument that A) there are now two known discrete discreet 
biological events that are pertinent to determining a future individual’s identity; namely, 
fertilization and the additional discrete biological event of epigenetic resetting of that 
individual’s biological organismic clock to time zero (t=0) around day 15 of 
embryogenesis and B) those two discrete discreet biological events are immersed in a 
continual complex developmental process that spans pre-fertilization and gestational 
intervals that drives individualization of diverse attributes of each future individual 
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human preceding the discrete blatant biological event of birth and societal entry of that 
human. During prenatal development, each future human is subject to various and 
variable exposures of the gravida to multiple physical, chemical, biological and social 
factors as well as to its own unique maternal in utero environment. These diverse 
exogenous exposures of every embryo/fetus influence its morphogenesis and 
physiogenesis thereby individualizing its future attributes, health and functional well-
being across its individual human lifespan within society. 
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Fig. 1 Changes in the Important Epigenetic Mechanism known as DNA Methylation. The 
DNA in parental gametes has many attached methyl groups. Soon after fertilization, the 
vast majority but not all of those pre-existing methylation "marks" on the DNA are 
removed. In the zygote, there are specific demethylation mechanisms that produce the 
major first wave of reprogramming of the epigenome. Soon after implantation, the newly 
reported event of resetting of the epigenetic organismic clock to “time zero” (Kerepesi et 
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al. 2021) occurs at about embryonic day 15, and then DNA re-methylation accelerates 
in association with rapid differentiation of the embryo. Thereafter, differentiated somatic 
cells in the embryo, fetus and infant have particular DNA methylation patterns that seem 
to mostly be sustained across the rest of the individual's lifespan. (Redrawn from 
Tuscher and Day 2019). 
Figure 2
Fig. 2 Sources of Diversity for Developmental Individualization of Potential and Future 
Humans. Pre-societal continuous individualization for a future individual human spans 
the other discrete events and encompasses multiple exogenous factors. Along the 
timeline of individual prenatal development, known paternal developmental influences 
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are more clustered in earlier stages, while maternal and intrauterine developmental 
influences rather obviously continue up through completion of parturition. 
